Interesting Neuro: Stroke Warning & Cluster Headache
May news includes ground-breaking FDA approvals, predictions of Alzheimer disease, and a possible biomarker for mild traumatic brain injury.
Status Epilepticus: Efficacy of IV Drugs
A study tested four different efficacy criteria for comparing intravenous antiepileptic drugs (AEDs) used to end status epilepticus.
Seizures and Encephalitis in Children with Flu
The first study of its kind in Australia examined influenza-associated neurological disease in hospitalized children.
New SUDEP Guidelines Clarify Risk Factors
The new SUDEP guidelines, co-developed by the AAN & AES and presented this week at the AAN Annual Meeting, provide clarity to health professionals.
Lennox-Gastaut Syndrome: Cannabidiol Treatment
What was the impact of add-on cannabidiol treatment in patients aged 2-55 years experiencing drop seizures?
Interesting Neuro: New Drugs & TBI Recovery
April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.
Refractory Epilepsy: Cannabinoid Challenges & Benefits
Experimental data suggesting benefits of cannabinoid comes from purified, standardized preparations that may not translate to real world practice.
Neuro News Roundup: Stroke Outcomes
Studies include stroke risk with epilepsy, genetic predisposition for ischemic stroke, and dysphagia screening in stroke patients.
Interesting Neuro: Tumor Tx and Stroke Recovery
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
Epilepsy, Syncope, or Both?
Common presentations between epilepsy and syncope complicate the differential diagnosis, making syncope the most frequent misdiagnosis in epilepsy.